Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 2140681 | HLA-DRB1*04 | polyp | NA | NA | NA | unclassified | |
| human autoantibodies against the 70-kd polypeptide of u1 small nuclear rnp are associated with hla-dr4 among connective tissue disease patients. | |||||||
| 2140681 | HLA-DRB1*04 | systemic lupus erythematosus | NA | NA | NA | positive | |
| the frequencies of hla-dr4 and hla-drw53 were increased among the anti-u1-70-kd autoantibody positive ctd group compared with the frequencies in anti-u1-70-kd autoantibody negative systemic lupus erythematosus patients and compared with normal controls. | |||||||
| 2140681 | HLA-DRW53 (HLA-DRB4) | systemic lupus erythematosus | NA | NA | NA | positive | |
| the frequencies of hla-dr4 and hla-drw53 were increased among the anti-u1-70-kd autoantibody positive ctd group compared with the frequencies in anti-u1-70-kd autoantibody negative systemic lupus erythematosus patients and compared with normal controls. | |||||||
| 2251494 | HLA-DR3 (BROAD ANTIGEN) | connective tissue disease | NA | dexamethasone | NA | unclassified | |
| mothers with an elevated risk of fetal chb can be identified by their history (underlying systemic connective tissue disease, previous pregnancies with chb), an immunogenetic predisposition (hla-dr3) and analysis of the ss-a/ss-b antibody pattern. | |||||||
| 2347134 | HLA (HLA) | connective tissue disease | Greek | NA | NA | unclassified | |
| on the other hand some of the differences, in accordance with other peculiarities of greeks with connective tissue disease, emphasize the role of racial and/or ethnic background in the hla-association of various autoimmune diseases and the fact that the detectable hla alloantigens in certain diseases modify disease and autoantibody expression rather than being responsible for the autoimmune process itself. | |||||||
| 2347134 | HLA (HLA) | autoimmune diseases | Greek | NA | NA | unclassified | |
| on the other hand some of the differences, in accordance with other peculiarities of greeks with connective tissue disease, emphasize the role of racial and/or ethnic background in the hla-association of various autoimmune diseases and the fact that the detectable hla alloantigens in certain diseases modify disease and autoantibody expression rather than being responsible for the autoimmune process itself. | |||||||
| 2347134 | HLA (HLA) | systemic lupus erythematosus | Greek | NA | NA | unclassified | |
| hla alloantigens in greek patients with systemic lupus erythematosus. | |||||||
| 2347134 | HLA-A (HLA-A) | systemic lupus erythematosus | Greek | NA | NA | unclassified | |
| the frequency of the hla-a, -b and -dr alloantigens was studied in 74 unselected, consecutive, unrelated greek patients with systemic lupus erythematosus (sle) and the results were compared with those of healthy controls (380 for the class i antigens and 154 for the class ii antigens). | |||||||
| 2347134 | HLA-DR (HLA-DR) | systemic lupus erythematosus | Greek | NA | NA | unclassified | |
| the frequency of the hla-a, -b and -dr alloantigens was studied in 74 unselected, consecutive, unrelated greek patients with systemic lupus erythematosus (sle) and the results were compared with those of healthy controls (380 for the class i antigens and 154 for the class ii antigens). | |||||||
| 2743090 | HLA-DR (HLA-DR) | connective tissue disease | NA | NA | NA | unclassified | |
| lymphocytic infiltrates and epithelial hla-dr expression in lip salivary glands in connective tissue disease patients lacking sicca: a prospective study. | |||||||
Copyright 2024